Laboratory Question for the Week of March 31 2025
How would we code for a case when aspiration is performed with or without the preparation of smears on a superficial tissue, without radiologic guidance?
How would we code for a case when aspiration is performed with or without the preparation of smears on a superficial tissue, without radiologic guidance?
A pathology lab is performing an immunofluorescent study on a skin biopsy to evaluate immunoglobulin deposits. They’re using fluorescent-tagged antibodies for IgG, IgM, and C3, with examination under fluorescent microscopy. I understand that 88346 would be reported for the initial study, but if they also perform an additional antibody stain for fibrinogen, how would this be reported?
When is 81528 covered by Medicare part B?
When both qualitative and quantitative antibody tests are performed on the same specimen, should both tests be billed separately, or is only one reportable?
What are the key compliance requirements and challenges associated with standing orders for laboratory services under Medicare regulations?
What are the key compliance requirements and challenges associated with standing orders for laboratory services under Medicare regulations?
What are the key changes introduced in the 2025 ICD-10-CM code update regarding specificity and claim processing?
When performing flow cytometry for cell enumeration, should CPT® codes 88184 or 88185 ever be reported separately, or are these inherently bundled? Additionally, if a pathologist provides a distinct interpretation of the flow cytometry results, is there any scenario where CPT codes 88187-88189 could be reported separately, or is the interpretation always included in the procedure?
A laboratory is implementing a new HPV assay that uses in vitro PCR technology to simultaneously test both high-risk pooled and individual results. As of 2025, which CPT® code should be reported for this service, and which Category III code has been deleted in conjunction with this update?
How does the introduction of new 2025 code 87626 for HPV testing differ from CPT code 87624, and what implications does the deletion of Category III code 0500T in 2025 have on reporting practices?
What conditions must be met to report code 81515 for and what are the implications of its CLIA-waived status when reported with modifier QW starting January 1, 2025?
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Notifications